Nukkleus (NASDAQ:DFNS – Get Free Report) posted its earnings results on Wednesday. The company reported ($1.14) earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $3.65 million during the quarter.
Nukkleus Stock Performance
DFNS opened at $0.36 on Friday. The stock has a market capitalization of $13.53 million, a PE ratio of 0.02 and a beta of -5.98. The stock’s 50 day moving average price is $0.67 and its 200-day moving average price is $2.75. Nukkleus has a 52-week low of $0.33 and a 52-week high of $23.00.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on DFNS shares. Weiss Ratings reissued a “sell (d+)” rating on shares of Nukkleus in a research note on Monday, March 23rd. Wall Street Zen cut Nukkleus from a “hold” rating to a “sell” rating in a research note on Saturday, April 18th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Nukkleus currently has an average rating of “Sell”.
Institutional Investors Weigh In On Nukkleus
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets purchased a new stake in Nukkleus in the second quarter worth $56,000. State Street Corp grew its stake in Nukkleus by 70.7% in the fourth quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after purchasing an additional 7,400 shares during the period. Price T Rowe Associates Inc. MD purchased a new stake in Nukkleus in the fourth quarter worth $57,000. GM Advisory Group LLC purchased a new stake in Nukkleus in the fourth quarter worth $56,000. Finally, Millennium Management LLC purchased a new stake in Nukkleus in the fourth quarter worth $60,000. 12.47% of the stock is owned by hedge funds and other institutional investors.
About Nukkleus
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.
Featured Articles
- Five stocks we like better than Nukkleus
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
- Intuit’s Great SaaS Reset: Fired By AI
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.
